Published on: 19-Oct-2026
Table of Contents
Introduction
An injured athlete today often comes back with a dataset: GPS sprint distances from rehab sessions, heart rate trends, sleep scores, sometimes sensor-based hop test asymmetries. That information can make return-to-play decisions more objective. It can also create false confidence. The useful question is not whether to trust the data or the clinician, but how each covers the other’s blind spots. The 2016 international consensus on return to sport described it as a continuum that runs alongside rehabilitation rather than a single pass-fail test at the end, and that is where wearables fit best.
What Wearables Actually Measure
Most devices used in rehab capture external load, meaning what the athlete did (distance, high-speed running, accelerations, decelerations, jump counts), or internal load, meaning how the body responded (heart rate, heart rate variability). Team-grade GPS units and inertial sensors are generally reliable for running volume and speed. Consumer devices vary more. A 2020 systematic review of 158 studies found commercial wearables accurate for steps and heart rate in lab settings, with accuracy depending on brand and model, while no brand estimated energy expenditure accurately. Sleep and “readiness” scores rest on even thinner validation. Before any number influences a clearance decision, the clinician should know which device produced it and how well that metric has been tested.
Where Data Earns Its Place
Wearables are most valuable in the later phases of rehab, when an athlete moves from controlled drills toward unpredictable, sport-specific work. In field sports, practitioners use GPS to rebuild high-speed running and sprint exposure toward the athlete’s pre-injury levels before full team training. Without that data, it is easy to clear a hamstring patient who has passed strength and range-of-motion tests but hasn’t approached top speed since the injury. Inertial sensors can also flag between-limb asymmetries during hops and landings after ACL reconstruction, outside the lab. These measures complement the strength and movement testing covered in our look at objective testing for return-to-sport decisions.
Where Data Falls Short
The cautionary example is the acute:chronic workload ratio (ACWR). For several years it was promoted as a way to predict injury from sudden spikes in training load. Later methodological critiques argued that the ratio introduces statistical artifacts and lacks a causal basis; one analysis found the injury association persisted even when the chronic component was replaced with contrived values. The broader lesson is that load metrics show whether an athlete completed the planned work and how they tolerated it. They cannot tell a clinician whether a particular progression raises or lowers injury risk.
Wearables also miss much of what matters in a return: tissue healing, pain behavior, movement quality under fatigue and psychological readiness. Fear of reinjury doesn’t show up on a GPS trace.
Integrating Data Into Clinical Judgment
The Strategic Assessment of Risk and Risk Tolerance (StARRT) framework offers a structure for combining both. It splits the decision into three steps: assessing tissue health, assessing the risk of the activity the athlete is returning to, and weighing risk-tolerance modifiers such as timing in the season, competitive pressure and the athlete’s own goals. Wearable data mainly informs the second step, showing whether the athlete has actually been exposed to the demands of the sport. It rarely answers the first or third.
Integration also depends on workflow. Device data that sits in a separate app nobody checks adds noise, not insight. Clinics and team medical staffs that bring it into a shared record, sometimes working with an mhealth app development company to place sensor exports alongside clinician notes, make it easier to read trends instead of isolated readings. The value comes from trend lines interpreted by someone who knows the athlete, not from automated thresholds. Medical clearance and true readiness are separate milestones, a gap explored in why cleared to play is not the same as ready to play.
Questions to Ask Before Clearance
- Has the athlete reached pre-injury levels of the sport’s key demands, such as top speed, change-of-direction volume and contact?
- Do strength and movement test results agree with what the wearable data shows?
- Is the athlete confident, or is hesitation showing up in how they move?
- What are the consequences if the decision is wrong, and who shares that risk?
Key Takeaway
Wearables make return-to-play decisions better informed by documenting what an athlete has actually done in rehab. They do not make the decision. Treat the data as one input within a structured framework, and let clinical judgment weigh what the sensors can’t measure.
FAQ
Can a smartwatch tell me when I’m ready to return to sport?
No. Consumer devices track heart rate and activity reasonably well, but readiness depends on tissue healing, strength, movement quality and confidence, which require clinical assessment.
Which wearable data matters most in return to play?
For running and field sports, high-speed running, sprint exposure, accelerations and decelerations are usually most relevant, compared against the athlete’s own pre-injury baseline.
Is the acute:chronic workload ratio reliable for predicting injury?
Current evidence does not support using it that way. Load data is better used to confirm that planned training was completed and tolerated.
Should recreational athletes use wearables during rehab?
They can help with adherence and gradual progression, but return decisions should rest with a clinician who can interpret the data in context.
Sponsored article. Researched and written independently by the Sports Medicine Weekly editorial team. Sports Medicine Weekly LLC does not endorse any product or service described on this site. Content published in Sports Medicine Weekly is for informational purposes only and is not a substitute for professional medical advice. Always seek the advice of your healthcare provider regarding any medical condition.
Resources
- Ardern CL, et al. 2016 Consensus statement on return to sport from the First World Congress in Sports Physical Therapy, Bern. Br J Sports Med. 2016;50(14):853–864. doi:10.1136/bjsports-2016-096278
- Shrier I. Strategic Assessment of Risk and Risk Tolerance (StARRT) framework for return-to-play decision-making. Br J Sports Med. 2015;49(20):1311–1315. doi:10.1136/bjsports-2014-094569
- Fuller D, et al. Reliability and validity of commercially available wearable devices for measuring steps, energy expenditure, and heart rate: systematic review. JMIR Mhealth Uhealth. 2020;8(9):e18694. doi:10.2196/18694
- Impellizzeri FM, et al. Training load and its role in injury prevention, part 2: conceptual and methodologic pitfalls. J Athl Train. 2020;55(9):893–901. doi:10.4085/1062-6050-501-19
- Impellizzeri FM, et al. What role do chronic workloads play in the acute to chronic workload ratio? Time to dismiss ACWR and its underlying theory. Sports Med. 2021;51(3):581–592. doi:10.1007/s40279-020-01378-6
The post Wearables in Return-to-Play Decisions: Data Versus Clinical Judgment appeared first on Sports Medicine Weekly.